About Repligen
Repligen is a Healthcare company based in Bridgewater (United States) founded in 1985, and was acquired by Repligen in April 2019. Medical device outsourcing services are provided to clients. It operates on a Professional Services and Direct-to-Consumer (D2C) model. Repligen offers products and services including Process Analytical Technology (PAT), XCell ATF Systems, KrosFlo TFF Systems, and OPUS Pre-packed Columns. Its focus areas include Biotechnology and Bioprocessing Equipment. Its legal entity is Repligen Corporation.
Company details
Repligen is involved in the development and supply of advanced bioprocessing technologies. Solutions are offered for upstream and downstream processes, including process analytical technology (PAT), filtration systems, chromatography, and fluid management. The company serves sectors such as gene therapy, cell therapy, and biologics, supporting therapeutic innovation. Real-time monitoring and optimization tools are provided to enhance manufacturing efficiency and ensure product quality across various modalities like antibodies, viral vectors, and mRNA.
- Headquarters Bridgewater, United States
- Stage Acquired
- SectorsHealthcare
- Website ctechnologiesinc.com
- Social LinkedIn YouTube
- Acquired by Repligen (Apr 2019)
- Legal Name Repligen Corporation
Products & Services of Repligen
Repligen offers a comprehensive portfolio of products and services, including Process Analytical Technology (PAT), XCell ATF Systems, KrosFlo TFF Systems, and OPUS Pre-packed Columns.
Solutions for real-time bioprocessing monitoring are provided.
Filtration systems for upstream bioprocessing are offered.
Tangential flow filtration systems are designed for bioprocessing.
Pre-packed chromatography columns for purification are supplied.
Apps and channels of Repligen
its YouTube channel Repligen has 1.1K subscribers and 30 videos.
Videos from Repligen
The most watched videos on Repligen's YouTube channel, Repligen (1.1K subscribers). Click a video to play it here.
More on Repligen.
Investors in Repligen
Repligen has secured backing from 1 investor. Prominent investors backing the company include Repligen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Products and services for biologic drug manufacturing are supplied. | 1981 | repligen.com | Waltham, United States |
Investor details for Repligen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Repligen
2 dated milestones of Repligen across 34 years, from founding to its latest funding, stage changes and deals.
- Founded Repligen is founded.
- Exit Acquired by Repligen.
Top companies in Medical Device Tech & Outsourcing
3 companies that operate in the same segment as Repligen (Medical Device Tech & Outsourcing) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Home medical and respiratory equipment and supplies are distributed. | 2005 | Phoenixville, Pennsylvania, United States | USD 4 M | USD 3.24 B | 10,500 | |
Cybersecurity solutions for medical devices are provided by MedCrypt. | 2016 | San Diego, California, United States | USD 63.75 M | |||
Laboratory and production supplies and services are provided. | 1902 | Hampton, Virginia, United States | 592 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Repligen
Repligen was founded in 1985.
Repligen is headquartered in Bridgewater, United States. It is registered at Bridgewater, New Jersey, United States.
Repligen is involved in the development and supply of advanced bioprocessing technologies. Solutions are offered for upstream and downstream processes, including process analytical technology (PAT), filtration systems, chromatography, and fluid management. The company serves sectors such as gene therapy, cell therapy, and biologics, supporting therapeutic innovation. Real-time monitoring and optimization tools are provided to enhance manufacturing efficiency and ensure product quality across various modalities like antibodies, viral vectors, and mRNA.
Repligen offers Process Analytical Technology (PAT), XCell ATF Systems, KrosFlo TFF Systems, and OPUS Pre-packed Columns.
Repligen has 1 investor. Key investors include Repligen.
Repligen operates through Repligen Corporation.
Yes. Repligen was acquired by Repligen in April 2019.